Copyright
©The Author(s) 2025.
World J Cardiol. Dec 26, 2025; 17(12): 111468
Published online Dec 26, 2025. doi: 10.4330/wjc.v17.i12.111468
Published online Dec 26, 2025. doi: 10.4330/wjc.v17.i12.111468
Figure 1 Journey of various trials of sirolimus and paclitaxel drug-coated balloons in clinical practice.
The blue color represents the paclitaxel drug, and green represents sirolimus. The names inside the balloon refer to commercially available drug-coated balloon (DCB), while the boxes represent the names of trials. It can be seen that initially all trials were done with paclitaxel-eluting DCBs, but of late studies have evaluated sirolimus DCBs.
- Citation: Bhandari M, Pradhan A, Behera S, Singh AK. Coronary drug-coated balloons: Current evidence and emerging trends. World J Cardiol 2025; 17(12): 111468
- URL: https://www.wjgnet.com/1949-8462/full/v17/i12/111468.htm
- DOI: https://dx.doi.org/10.4330/wjc.v17.i12.111468
